Ampio Pharma (AMPE) Issues Prelim. Update on Optina Clinical Trial; Concluded Study Ahead of Schedule, to Request Meeting with FDA
Go back to Ampio Pharma (AMPE) Issues Prelim. Update on Optina Clinical Trial; Concluded Study Ahead of Schedule, to Request Meeting with FDA| AMPIO PHARMACEUTICALS, Inc. (AMEX: AMPE) | Delayed: 0.18 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.18 | 52 Week High | $4.32 | |||
| Open | $0.18 | 52 Week Low | $0.59 | |||
| Day High | $0.18 | P/E | N/A | |||
| Day Low | $0.18 | EPS | $-0.63 | |||
| Volume | 1,000 | |||||
